GlassScriptPhysician profile
Michael Joseph Heiferman
NPI 1336538982
$8,739.16
in general payments reported to CMS, 2019-2025
17 companies · $3,613 in 2025
The $3,613 reported for 2025 was more than what 92% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,654 · 2020: $480 · 2021: $505 · 2022: $499 · 2023: $279 · 2024: $709 · 2025: $3,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,880 · Food and Beverage: $1,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,880.00 |
| Food and Beverage | $1,720.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunocore Limited | $3,060.62 | 2025 | Kimmtrak |
| Alcon Vision LLC | $2,520.81 | 2019-2025 | Ngenuity, Constellation, Clareon |
| Regeneron Healthcare Solutions, INC. | $705.44 | 2019-2025 | Eylea Hd |
| Allergan, INC. | $391.25 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $279.64 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $247.79 | 2019 | |
| Dutch Ophthalmic, USA | $241.65 | 2024 | Eva, Combined Machine, Tissueblue |
| Alimera Sciences, INC. | $235.92 | 2020-2024 | Yutiq, Iluvien |
| Eyepoint US, INC. | $150.00 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $150.00 | 2025 | |
| Astellas Pharma Global Development | $148.99 | 2025 | Izervay |
| Astellas Pharma US INC | $145.53 | 2023 | |
| Regeneron Pharmaceuticals, INC. | $135.22 | 2024 | Eylea Hd |
| Johnson & Johnson Surgical Vision, INC. | $128.87 | 2019 | |
| Genentech USA, INC. | $111.48 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $67.87 | 2024-2025 | Syfovre |
| Abbvie INC. | $18.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Heiferman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.